China Gets First Joint-Venture CRO
This article was originally published in PharmAsia News
Executive Summary
Rundo Cronova Clinical Research (Shanghai) Co., China's first joint venture contract research organization venture between Rundo International Clinical Research Co. and Japan's Cronova, was officially established Dec. 19, 2007. Rundo and Cronova hold 65 percent and 35 percent stakes of the new company, respectively. Rundo, a well-known China CRO, focuses on clinical research business with international partners while Cronova is a leading CRO in Japan. Both firms intend to raise their profiles with plans to open up to three subsidiaries or branch offices in China within a year. (Click here for more)